Australia's Microba Life Sciences slips on fall in quarterly revenue
** Shares of Microba Life Sciences MAP.AX fall as much as 3.8% to A$0.076, their biggest intraday pct fall since October 10; stock last down 2.5% ** Health sciences co reports quarterly revenue of A$3.6 million ($2.34 million), down 1% vs pcp ** Stock is down 60.5% YTD, including the session's moves ($1 = 1.5389 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement